<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38441464</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>02</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Construction of an infectious clone for enterovirus A89 and mutagenesis analysis of viral infection and cell binding.</ArticleTitle><Pagination><StartPage>e0333223</StartPage><MedlinePgn>e0333223</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e03332-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.03332-23</ELocationID><Abstract><AbstractText>Enterovirus A89 (EV-A89) is an unconventional strain belonging to the <i>Enterovirus A</i> species. Limited research has been conducted on EV-A89, leaving its biological and pathogenic properties unclear. Developing reverse genetic tools for EV-A89 would help to unravel its infection mechanisms and aid in the development of vaccines and anti-viral drugs. In this study, an infectious clone for EV-A89 was successfully constructed and recombinant enterovirus A89 (rEV-A89) was generated. The rEV-A89 exhibited similar characteristics such as growth curve, plaque morphology, and dsRNA expression with parental strain. Four amino acid substitutions were identified in the EV-A89 capsid, which were found to enhance viral infection. Mechanistic studies revealed that these substitutions increased the virus's cell-binding ability. Establishing reverse genetic tools for EV-A89 will significantly contribute to understanding viral infection and developing anti-viral strategies.IMPORTANCE<i>Enterovirus A</i> species contain many human pathogens and have been classified into conventional cluster and unconventional cluster. Most of the research focuses on various conventional members, while understanding of the life cycle and infection characteristics of unconventional viruses is still very limited. In our study, we constructed the infectious cDNA clone and single-round infectious particles for the unconventional EV-A89, allowing us to investigate the biological properties of recombinant viruses. Moreover, we identified key amino acids residues that facilitate EV-A89 infection and elucidate their roles in enhancing viral binding to host cells. The establishment of the reverse genetics system will greatly facilitate future study on the life cycle of EV-A89 and contribute to the development of prophylactic vaccines and anti-viral drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1114-7505</Identifier><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaohong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Miaomiao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2692-5437</Identifier><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jianqing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0896-9273</Identifier><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-3193-1401</Identifier><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuye</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4749-6790</Identifier><AffiliationInfo><Affiliation>Clinical Center for Biotherapy, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82002135</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>82172250</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>KY-GW-2020-03</GrantID><Agency>Shanghai Public Health Clinical Center</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002999" MajorTopicYN="N">Clone Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus A89</Keyword><Keyword MajorTopicYN="N">infectious clone</Keyword><Keyword MajorTopicYN="N">reverse genetics</Keyword><Keyword MajorTopicYN="N">site mutations</Keyword><Keyword MajorTopicYN="N">subgenomic replicon</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>10</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38441464</ArticleId><ArticleId IdType="pmc">PMC10986554</ArticleId><ArticleId IdType="doi">10.1128/spectrum.03332-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yi EJ, Shin YJ, Kim JH, Kim TG, Chang SY. 2017. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res 6:4–14. doi:10.7774/cevr.2017.6.1.4</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Ji W, Chen S, Duan G, Jin Y. 2023. Hand, foot, and mouth disease challenges and its antiviral therapeutics. Vaccines 11:571. doi:10.3390/vaccines11030571</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030571</ArticleId><ArticleId IdType="pmc">PMC10054684</ArticleId><ArticleId IdType="pubmed">36992155</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Chen J, Zhang M, Guo W, Feng C, Liu J, Xu L, Gao N, Ma S. 2023. Coxsackievirus B: the important agent of hand, foot, and mouth disease. J Med Virol 95:e28669. doi:10.1002/jmv.28669</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28669</ArticleId><ArticleId IdType="pubmed">36912377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Yoshida H, Ding Z, Tao Z, Zhang J, Tian B, Zhao Z, Zhang L. 2014. Molecular epidemiology and recombination of human enteroviruses from AFP surveillance in Yunnan, China from 2006 to 2010. Sci Rep 4:6058. doi:10.1038/srep06058</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep06058</ArticleId><ArticleId IdType="pmc">PMC5377527</ArticleId><ArticleId IdType="pubmed">25317568</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams MJ, Lefkowitz EJ, King AMQ, Bamford DH, Breitbart M, Davison AJ, Ghabrial SA, Gorbalenya AE, Knowles NJ, Krell P, Lavigne R, Prangishvili D, Sanfaçon H, Siddell SG, Simmonds P, Carstens EB. 2015. Ratification vote on taxonomic proposals to the international committee on taxonomy of viruses (2015). Arch Virol 160:1837–1850. doi:10.1007/s00705-015-2425-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2425-z</ArticleId><ArticleId IdType="pubmed">25913692</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778–790. doi:10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Michele SM, Belliot G, Uddin M, Pallansch MA. 2005. Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A. J Gen Virol 86:445–451. doi:10.1099/vir.0.80475-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80475-0</ArticleId><ArticleId IdType="pubmed">15659764</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Zhu L, Fan J, Yan J, Dun Y, Yu R, Liu L, Zhang S. 2020. Rules governing genetic exchanges among viral types from different Enterovirus A clusters. J Gen Virol 101:1145–1155. doi:10.1099/jgv.0.001479</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001479</ArticleId><ArticleId IdType="pmc">PMC7879560</ArticleId><ArticleId IdType="pubmed">32762804</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Feeroz MM, Maher K, Nix WA, Engel GA, Hasan KM, Begum S, Oh G, Chowdhury AH, Pallansch MA, Jones-Engel L. 2013. Characterizing the picornavirus landscape among synanthropic nonhuman primates in Bangladesh. J Virol 87:558–571. doi:10.1128/JVI.00837-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00837-12</ArticleId><ArticleId IdType="pmc">PMC3536389</ArticleId><ArticleId IdType="pubmed">23097448</ArticleId></ArticleIdList></Reference><Reference><Citation>Laxmivandana R, Yergolkar P, Gopalkrishna V, Chitambar SD. 2013. Characterization of the non-polio enterovirus infections associated with acute flaccid paralysis in South-Western India. PLoS One 8:e61650. doi:10.1371/journal.pone.0061650</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061650</ArticleId><ArticleId IdType="pmc">PMC3632520</ArticleId><ArticleId IdType="pubmed">23630606</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitambar S, Gopalkrishna V, Chhabra P, Patil P, Verma H, Lahon A, Arora R, Tatte V, Ranshing S, Dhale G, Kolhapure R, Tikute S, Kulkarni J, Bhardwaj R, Akarte S, Pawar S. 2012. Diversity in the enteric viruses detected in outbreaks of gastroenteritis from Mumbai, Western India. Int J Environ Res Public Health 9:895–915. doi:10.3390/ijerph9030895</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph9030895</ArticleId><ArticleId IdType="pmc">PMC3367285</ArticleId><ArticleId IdType="pubmed">22690171</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao CD, Yergolkar P, Shankarappa KS. 2012. Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007-2009. Emerg Infect Dis 18:1833–1840. doi:10.3201/eid1811.111457</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1811.111457</ArticleId><ArticleId IdType="pmc">PMC3559176</ArticleId><ArticleId IdType="pubmed">23092622</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil PR, Chitambar SD, Gopalkrishna V. 2015. Molecular surveillance of non-polio enterovirus infections in patients with acute gastroenteritis in Western India: 2004-2009. J Med Virol 87:154–161. doi:10.1002/jmv.23992</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23992</ArticleId><ArticleId IdType="pubmed">24903844</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S, Paananen A, Savolainen-Kopra C, Hovi T, Roivainen M. 2008. Eight years of experience with molecular identification of human enteroviruses. J Clin Microbiol 46:2410–2413. doi:10.1128/JCM.00313-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00313-08</ArticleId><ArticleId IdType="pmc">PMC2446933</ArticleId><ArticleId IdType="pubmed">18463218</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Q, Zhang Y, Hu L, Sun Q, Cui H, Yan D, Sikandaner H, Tang H, Wang D, Zhu Z, Zhu S, Xu W. 2015. A novel recombinant enterovirus type EV-A89 with low epidemic strength in Xinjiang, China. Sci Rep 5:18558. doi:10.1038/srep18558</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep18558</ArticleId><ArticleId IdType="pmc">PMC4685259</ArticleId><ArticleId IdType="pubmed">26685900</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello VR, Baltimore D. 1981. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214:916–919. doi:10.1126/science.6272391</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6272391</ArticleId><ArticleId IdType="pubmed">6272391</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Tee HK, Lee MHP, Sam I-C, Chan YF. 2016. Enterovirus A71 DNA-launched infectious clone as a robust reverse genetic tool. PLoS One 11:e0162771. doi:10.1371/journal.pone.0162771</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162771</ArticleId><ArticleId IdType="pmc">PMC5019408</ArticleId><ArticleId IdType="pubmed">27617744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YX, Wei T, Li XY, Yin X, Li YH, Ding JW, Zhou JM, Zhang GZ, Jin Q, Cen S. 2013. Construction and characterization of an infectious cDNA clone of enterovirus type 71 subgenotype C4. Virus Genes 47:235–243. doi:10.1007/s11262-013-0955-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-013-0955-6</ArticleId><ArticleId IdType="pubmed">23877719</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T. 2005. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 86:1391–1401. doi:10.1099/vir.0.80784-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80784-0</ArticleId><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Li S, Liu Y, Hou W, Lin Q, Zhao H, Xu L, He D, Ye X, Zhu H, Cheng T, Xia N. 2015. Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice. Virus Res 210:165–168. doi:10.1016/j.virusres.2015.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.08.002</ArticleId><ArticleId IdType="pubmed">26272672</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Dan H, Zhao X, Chen H, Chen Y, Zhang N, Mo Z, Liu H. 2019. Construction and characterization of an infectious cDNA clone of coxsackievirus A 10. Virol J 16:98. doi:10.1186/s12985-019-1201-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-019-1201-1</ArticleId><ArticleId IdType="pmc">PMC6685229</ArticleId><ArticleId IdType="pubmed">31387601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Yan J, Zhu L, Wang M, Liu L, Yu R, Chen M, Xun J, Zhang Y, Yi Z, Zhang S. 2020. The establishment of infectious clone and single round infectious particles for coxsackievirus A10. Virol Sin 35:426–435. doi:10.1007/s12250-020-00198-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00198-2</ArticleId><ArticleId IdType="pmc">PMC7462955</ArticleId><ArticleId IdType="pubmed">32144688</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C, Li X, Liu S, Xu L, Ye H, Qin CF, Zhang B. 2015. Development and characterization of a clinical strain of coxsackievirus A16 and an eGFP infectious clone. Virol Sin 30:269–276. doi:10.1007/s12250-015-3610-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-015-3610-7</ArticleId><ArticleId IdType="pmc">PMC8200862</ArticleId><ArticleId IdType="pubmed">26220729</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar HM, Melia CE, van Bruggen JAC, Strating J, van Geenen MED, Koster AJ, Bárcena M, van Kuppeveld FJM. 2016. Illuminating the sites of enterovirus replication in living cells by using a split-GFP-tagged viral protein. mSphere 1:e00104-16. doi:10.1128/mSphere.00104-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00104-16</ArticleId><ArticleId IdType="pmc">PMC4935779</ArticleId><ArticleId IdType="pubmed">27390781</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Cui B, Yang J, Hao X, Yan X, Zhang J, Liu D, Song Z, Wang Q, Mao Q, Liang Z. 2022. Construction and verification of an infectious cDNA clone of coxsackievirus B5. Virol Sin 37:469–471. doi:10.1016/j.virs.2022.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.03.005</ArticleId><ArticleId IdType="pmc">PMC9707635</ArticleId><ArticleId IdType="pubmed">35288348</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan M, Gao S, Zhou Z, Zhang K, Liu S, Wang Z, Wang T. 2018. A reverse genetics system for enterovirus D68 using human RNA polymerase I. Virus Genes 54:484–492. doi:10.1007/s11262-018-1570-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-018-1570-3</ArticleId><ArticleId IdType="pubmed">29777445</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, Dong W, Wan X, Huang N, Shen X, Liang Z, Li W. 2012. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem 287:6406–6420. doi:10.1074/jbc.M111.301622</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M, Yan J, Xun J, Chen C, Zhang Y, Wang M, Chu W, Song Z, Hu Y, Zhang S, Zhang X. 2018. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases. Virol J 15:1. doi:10.1186/s12985-017-0913-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0913-3</ArticleId><ArticleId IdType="pmc">PMC5751926</ArticleId><ArticleId IdType="pubmed">29298696</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Nagata N, Sata T, Miyamura T, Shimizu H. 2006. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J Gen Virol 87:3317–3327. doi:10.1099/vir.0.82172-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82172-0</ArticleId><ArticleId IdType="pubmed">17030866</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Chen M, Wang M, Zhu L, Yan J, Zhang X, Xu J, Zhang S. 2022. Enterovirus A shows unique patterns of codon usage bias in conventional versus unconventional clade. Front Cell Infect Microbiol 12:941325. doi:10.3389/fcimb.2022.941325</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.941325</ArticleId><ArticleId IdType="pmc">PMC9329520</ArticleId><ArticleId IdType="pubmed">35909978</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert X, Gouet P. 2014. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42:W320–W324. doi:10.1093/nar/gku316</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku316</ArticleId><ArticleId IdType="pmc">PMC4086106</ArticleId><ArticleId IdType="pubmed">24753421</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. 2012. Crystal structure of human enterovirus 71. Science 336:1274. doi:10.1126/science.1218713</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. 2017. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 501:79–87. doi:10.1016/j.virol.2016.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Shi J, Ye X, Ku Z, Zhang C, Liu Q, Huang Z. 2017. Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor. Emerg Microbes Infect 6:e65. doi:10.1038/emi.2017.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.55</ArticleId><ArticleId IdType="pmc">PMC5567171</ArticleId><ArticleId IdType="pubmed">28745308</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R, Wang M, Liu L, Yan J, Fan J, Li X, Kang M, Xu J, Zhang X, Zhang S. 2022. The development and characterization of a stable coxsackievirus A16 infectious clone with Nanoluc reporter gene. Front Microbiol 13:1101850. doi:10.3389/fmicb.2022.1101850</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1101850</ArticleId><ArticleId IdType="pmc">PMC9871592</ArticleId><ArticleId IdType="pubmed">36704559</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Ami Y, Wakita T, Shimizu H. 2008. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol 82:1787–1797. doi:10.1128/JVI.01798-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z, Phuektes P, McMinn P. 2012. A reverse genetic study of the adaptation of human enterovirus 71 to growth in Chinese hamster ovary cell cultures. Virus Res 165:151–156. doi:10.1016/j.virusres.2012.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.02.009</ArticleId><ArticleId IdType="pubmed">22406130</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorio CBL, Xu Y, Ng Q, Chow VTK, Chua KB. 2014. Phenotypic and genotypic characteristics of novel mouse cell line (NIH/3T3)-adapted human enterovirus 71 strains (EV71:TLLm and EV71:TLLmv). PLoS ONE 9:e92719. doi:10.1371/journal.pone.0092719</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092719</ArticleId><ArticleId IdType="pmc">PMC3966832</ArticleId><ArticleId IdType="pubmed">24671184</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhang M, Feng C, Cong S, Xu D, Sun H, Yang Z, Ma S. 2021. Characterization of coxsackievirus A6 strains isolated from children with hand, foot, and mouth disease. Front Cell Infect Microbiol 11:700191. doi:10.3389/fcimb.2021.700191</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.700191</ArticleId><ArticleId IdType="pmc">PMC8418080</ArticleId><ArticleId IdType="pubmed">34490141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Yang T, Yue L, Li H, Xie T, Xiang H, Wang J, Wei X, Zhang Y, Xie Z. 2022. Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells. J Med Virol 94:3820–3828. doi:10.1002/jmv.27796</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27796</ArticleId><ArticleId IdType="pubmed">35437759</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87:611–620. doi:10.1128/JVI.02226-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, McLaughlin NP, Pan J, Goldstein S, Hafenstein S, Shimizu H, Winkler JD, Bergelson JM. 2015. The Suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate. PLoS Pathog 11:e1005184. doi:10.1371/journal.ppat.1005184</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005184</ArticleId><ArticleId IdType="pmc">PMC4592248</ArticleId><ArticleId IdType="pubmed">26430888</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold J, Andino R. 2000. Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis. J Virol 74:6394–6400. doi:10.1128/jvi.74.14.6394-6400.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.14.6394-6400.2000</ArticleId><ArticleId IdType="pmc">PMC112146</ArticleId><ArticleId IdType="pubmed">10864650</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE. 2021. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 30:70–82. doi:10.1002/pro.3943</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3943</ArticleId><ArticleId IdType="pmc">PMC7737788</ArticleId><ArticleId IdType="pubmed">32881101</ArticleId></ArticleIdList></Reference><Reference><Citation>Goddard TD, Huang CC, Meng EC, Pettersen EF, Couch GS, Morris JH, Ferrin TE. 2018. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci 27:14–25. doi:10.1002/pro.3235</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3235</ArticleId><ArticleId IdType="pmc">PMC5734306</ArticleId><ArticleId IdType="pubmed">28710774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>